Sun Pharmaceutical Industries, Inc.
Princeton, NJ
- UEI
- CN7NRYVDXEA7
- CAGE
- 0PUV4
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 2 Independence Way, Princeton, NJ 08540, USA
- Website
- sunpharma.com
- Founded
- 1983
- Employees
- 10K-50K
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Radiopharmaceuticals | Defense Health Agency | $19,003 | |
| Various radiopharmaceuticals, department of radiology nuclear medicine | Medical Command | $104,245 | |
| Radiopharmaceuticals | Defense Health Agency | $21,839 | |
| Radiopharmaceuticals for nuclear medicine. | Defense Health Agency | $21,834 | |
| Nuclear medicine imaging products for myocardial infarct imaging, diagnostic imaging of gall bladder disorders, and… | Defense Health Agency | $781,762 |
About Sun Pharmaceutical Industries, Inc.
Sun Pharmaceutical Industries, Inc., a Princeton, New Jersey-based for-profit manufacturer of pharmaceutical and radiopharmaceutical products, operates exclusively as a prime contractor supplying nuclear medicine imaging products and radiopharmaceuticals to federal healthcare agencies under non-set-aside full-and-open competitive procurements. The company does not subcontract and does not pursue set-aside categories; all 50 awards in its federal portfolio are prime contracts or indefinite-delivery vehicles issued without small business designations.
Sun Pharmaceutical's federal footprint concentrates heavily within the Veterans Administration ecosystem, which accounts for roughly 72% of combined potential value across recent awards. The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 dominates this concentration with 5 awards carrying $300.3 million in combined potential value, while the Department of Veterans Affairs National Acquisition Center contributes 2 awards worth $26.7 million. The Defense Health Agency, Sun Pharmaceutical's second-largest customer by award count, holds 9 awards valued at $9.8 million combined, anchored by a $117.4 million Federal Supply Schedule contract under the Pharmaceuticals and Drugs schedule that runs through June 2026. This GSA Schedule serves as the primary vehicle for task orders placed by both the Defense Health Agency and the Department of Veterans Affairs.
Sun Pharmaceutical's capability portfolio centers on radiopharmaceuticals, isotopes, radiotracers, syringes, and shielding equipment used in nuclear medicine diagnostic imaging. Representative work includes a $521,223.75 purchase order awarded by the Defense Health Agency on November 15, 2025, for radiopharmaceuticals supporting the Department of Radiology Nuclear Medicine operations at Fort Sam Houston through September 2030; a $967,271.92 purchase order from March 2022 for nuclear medicine imaging products used in myocardial infarction, gallbladder, and breast cancer imaging; and a $250,000 single-award BPA awarded in June 2025 by the Defense Health Agency for radiation treatment agents running through June 2030. Recent BPA calls from the Defense Health Agency for radiopharmaceuticals have ranged from $19,003 to $21,839. The company's primary NAICS classification is Pharmaceutical Preparation Manufacturing (46 awards), with secondary activity in In-Vitro Diagnostic Substance Manufacturing.
Activity has been uneven across the past five years — two awards in 2020, one in 2021, two in 2022, then a gap to four awards in 2025 and one in 2026 — with only two awards (combined potential value $986 thousand) completing within the next twenty-four months. The gap between combined potential value ($465 million) and combined dollars obligated ($8.9 million, or 2% of potential) reflects the large but unobligated ceilings on indefinite-delivery vehicles, particularly the $117.4 million Federal Supply Schedule contract that anchors the portfolio.
Contract vehicles
Quick answers
What is Sun Pharmaceutical Industries, Inc.'s UEI?
Sun Pharmaceutical Industries, Inc.'s Unique Entity ID (UEI) in SAM.gov is CN7NRYVDXEA7.
What is Sun Pharmaceutical Industries, Inc.'s CAGE code?
Sun Pharmaceutical Industries, Inc.'s CAGE code is 0PUV4.
What is Sun Pharmaceutical Industries, Inc.'s primary NAICS code?
Sun Pharmaceutical Industries, Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Sun Pharmaceutical Industries, Inc. located?
Sun Pharmaceutical Industries, Inc.'s physical address in SAM.gov is 2 Independence Way, Princeton, NJ 08540, USA.
Is Sun Pharmaceutical Industries, Inc. registered in SAM.gov?
Yes. Sun Pharmaceutical Industries, Inc.'s SAM.gov registration is active through November 25, 2026.
Which contract vehicles does Sun Pharmaceutical Industries, Inc. hold?
Sun Pharmaceutical Industries, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Sun Pharmaceutical Industries, Inc.'s most recent federal award?
Sun Pharmaceutical Industries, Inc.'s most recent federal contract award is Radiopharmaceuticals (HT009026FG0110044), from Defense Health Agency, on January 8, 2026.
On GovTribe
See Sun Pharmaceutical Industries, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors